Crossmark

Recurrent heart failure hospitalizations increase the risk of mortality in heart failure patients with atrial fibrillation and type 2 diabetes mellitus in the United Kingdom: a retrospective analysis of Clinical Practice Research Datalink database

Crossref DOI link: https://doi.org/10.1186/s12872-022-02665-y

Published Online: 2022-05-21

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lahoz, Raquel

Fagan, Ailís

McSharry, Martin

Proudfoot, Clare

Corda, Stefano

Studer, Rachel
License Information

Text and Data Mining valid from 2022-05-21

Version of Record valid from 2022-05-21
More Information

Article History

Received: 16 September 2021

Accepted: 7 April 2022

First Online: 21 May 2022

Declarations

:

: This study was approved by an Independent Scientific Advisory Committee (ISAC);(protocol number 18_252R), directly from CPRD, UK as part of their research governance process. Because of the anonymous nature of this database, the requirement for informed consent was waived as CPRD has ethics approval from the UK’s Health Research Authority to support research using anonymised patient data (statement from ExternalRef removed). This study was approved via the CPRD Research Data Governance Process. All methods were carried out in accordance with relevant guidelines and regulations (declaration of Helsinki).

: Not applicable.

: RL, RS and CP are employees of Novartis Pharma AG and holds shares of Novartis Pharma AG. AF is an employee of Novartis Ireland Limited, Dublin. MMS was an employee of Novartis Ireland Limited, Dublin when this study was conducted and is currently an employee of Empower The User, Dublin. SC was an employee of Novartis Pharma AG when this study was conducted and is currently an employee of Bayer.

Document is current

Any future updates will be listed below